Incidence rates and HRs for diabetes by pulmonary conditions among participants aged 25–74 years, NHEFS, 1971–1975 to 1992–1993
| Pulmonary conditions . | No. of cases . | Person-years . | Unadjusted incidence per 100,000 person-years* . | Age-adjusted incidence per 100,000 person-years* . | HR (95% CI) . | . | . | ||
|---|---|---|---|---|---|---|---|---|---|
| . | . | . | . | . | Unadjusted . | Age-adjusted . | Multiple-adjusted† . | ||
| COPD (moderate or severe) | 46 | 5,647 | 711 | 604 | 1.54 (1.03–2.30) | 1.23 (0.84–1.81) | 1.02 (0.68–1.53) | ||
| COPD (mild) | 29 | 5,929 | 388 | 330 | 0.83 (0.51–1.35) | 0.66 (0.40–1.10) | 0.66 (0.39–1.12) | ||
| Symptoms | 78 | 12,221 | 616 | 679 | 1.31 (0.98–1.76) | 1.34 (1.00–1.81) | 1.06 (0.76–1.48) | ||
| RLD | 68 | 6,076 | 1,106 | 1047 | 2.38 (1.74–3.27) | 2.04 (1.47–2.81) | 1.45 (1.04–2.03) | ||
| Normal | 222 | 47,466 | 475 | 516 | 1.00 | 1.00 | 1.00 | ||
| P for overall test‡ | <0.001 | <0.001 | 0.032 | ||||||
| Pulmonary conditions . | No. of cases . | Person-years . | Unadjusted incidence per 100,000 person-years* . | Age-adjusted incidence per 100,000 person-years* . | HR (95% CI) . | . | . | ||
|---|---|---|---|---|---|---|---|---|---|
| . | . | . | . | . | Unadjusted . | Age-adjusted . | Multiple-adjusted† . | ||
| COPD (moderate or severe) | 46 | 5,647 | 711 | 604 | 1.54 (1.03–2.30) | 1.23 (0.84–1.81) | 1.02 (0.68–1.53) | ||
| COPD (mild) | 29 | 5,929 | 388 | 330 | 0.83 (0.51–1.35) | 0.66 (0.40–1.10) | 0.66 (0.39–1.12) | ||
| Symptoms | 78 | 12,221 | 616 | 679 | 1.31 (0.98–1.76) | 1.34 (1.00–1.81) | 1.06 (0.76–1.48) | ||
| RLD | 68 | 6,076 | 1,106 | 1047 | 2.38 (1.74–3.27) | 2.04 (1.47–2.81) | 1.45 (1.04–2.03) | ||
| Normal | 222 | 47,466 | 475 | 516 | 1.00 | 1.00 | 1.00 | ||
| P for overall test‡ | <0.001 | <0.001 | 0.032 | ||||||
Of 4,830 in the total sample, 443 people developed diabetes.
Estimate calculated using sampling weights.
Adjusted for age, sex, race or ethnicity, education, smoking status, systolic blood pressure, use of antihypertensive medication, cholesterol concentration, BMI, alcohol use, recreational exercise, and nonrecreational activity.
Wald χ2 test.